Eli Lilly stated that results from a late-stage trial of its pill variant of GLP-1 drugs met the requirements for global ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday.

Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.

What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.

Eli Lilly's Mounjaro matched Trulicity in heart outcomes and showed added benefits on A1C, weight, kidney function, and mortality in a major trial.

Eli Lilly and Company has confirmed it’s selling its manufacturing site in Branchburg. The decision was made following a ...

Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company's older diabetes treatment, Trulicity.